Abstract
Persistent left ventricular (LV) dysfunction after reperfused myocardial infarction (RMI) is a significant problem and angiotensin II (AngII) type 1 receptor (AT1R) blockers (ARBs) may limit reperfusion injury involving upregulation of AngII type 2 receptors (AT2R). To determine whether ARBs valsartan and irbesartan limit reperfusion injury and upregulate AT2R protein during RMI, we randomized dogs with anterior RMI (90 min ischemia; 120 min reperfusion) to 4 groups [valsartan (n = 6); irbesartan (n = 9); vehicle controls (n = 8); and sham (n = 6)] and measured serial in vivo hemodynamics, LV systolic and diastolic function, and inhibition of AngII pressor responses to the ARBs, and ex vivo infarct size, and regional AT1R and AT2R protein expression at the end of the reperfusion. Compared to the control group, both ARBs significantly limited the increase in left atrial pressure, promptly limited the deterioration of LV dP/dtmax, dP/dtmin, ejection fraction and diastolic function, limited infarct expansion and thinning, and limited infarct size. Importantly, both ARBs increased AT2R protein in the postischemic reperfused zone, with no change in AT1R protein. There were no changes in the sham group. The results suggest that limit...Continue Reading
Citations
Aug 17, 2005·Hypertension·Christine Maric
Oct 11, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Szilard VorosChristopher M Kramer
Jun 7, 2013·BMC Cardiovascular Disorders·Xiao-Cong ZengHong Wen
Oct 31, 2016·Asian Pacific Journal of Tropical Medicine·Tao WuPing Li
Aug 26, 2020·Journal of Cardiovascular Pharmacology and Therapeutics·Andrey V KrylatovLeonid N Maslov
Feb 27, 2007·Vascular Health and Risk Management·Bodh I Jugdutt
Aug 23, 2019·Journal of Cellular Biochemistry·Tao ZhangDi Wu
May 9, 2007·Pediatric Cardiology·C L CuaL D Nelin
May 22, 2007·Proteomics·Grzegorz Sawicki, Bodh I Jugdutt
Oct 12, 2011·Cardiovascular Drugs and Therapy·Yumei YeYochai Birnbaum
Sep 20, 2006·Hypertension·Thomas A BarkerBradford C Berk
May 6, 2014·Current Hypertension Reports·Elena KaschinaU Muscha Steckelings
Aug 24, 2011·Cardiovascular Drugs and Therapy·Xianwei WangJawahar L Mehta
Jun 8, 2017·Food & Function·Dong MingLiu Jie
Jan 15, 2014·Hypertension·Suang Suang KoidDuncan John Campbell
Nov 22, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Mikhail Y MaslovMark A Lovich
Apr 3, 2021·Molecular Pharmacology·Arina RanjitAli Aghazadeh-Habashi